Advances In™ Uveitic Macular Edema: The Future of Treatment for Patients With UME
March 31, 2021
March 31, 2022
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Physicians’ Education Resource®, LLC.
This activity is supported by an educational grant from Bausch + Lomb.
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
- Nurses — 1.0 Contact Hours
All other health care professionals completing this course will be issued a statement of participation.
This educational activity is directed toward ophthalmologists and other health care professionals involved in management of patients with uveitic macular edema.
This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of uveitic macular edema, with a forward-looking perspective on how new and novel agents might impact clinical practice. The essentials of diagnosis, current and emerging treatment strategies, and management of treatment-related toxicities will be presented in a multimedia format, including a series of video interviews with an expert thought leader integrated into text-based elements.
Upon successful completion of this activity, you should be better prepared to:
- Discuss the various etiologies of uveitic macular edema
- Evaluate clinical and imaging findings in a differential diagnosis of uveitic macular edema
- Describe the efficacy, safety, benefits, and limitations of existing and future corticosteroid treatments in patients with uveitic macular edema
Steven Yeh, MD
Stanley Truhlsen Jr. Professor of Ophthalmology
Director, Uveitis and Vitreoretinal Disease
Truhlsen Eye Institute
University of Nebraska Medical Center
Jessica G. Shantha, MD
Emory Eye Center
Division of Uveitis and Medical Retina
Physician Accreditation Statement
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician Credit Designation
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit Designation
Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.
Disclosures of Conflicts of Interest
Steven Yeh, MD
- Consultant: Bausch + Lomb
Jessica G. Shantha, MD
- Grant/Research Support: NEI K23
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Instructions for Participation and Credit
- Complete the activity (including pre- and post-activity assessments).
- Answer the evaluation questions.
- Request credit using the drop-down menu.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.